Nondrug interventions for treatment of hypertension

Journal of Clinical Hypertension

Volumn 13, Issue 11, 2011, Pages 829-835

  Woolf, Kevin J ^a   Bisognano, John D ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; FISH OIL; FLAVONOID; FOLIC ACID; FORSKOLIN; POTASSIUM; SOYBEAN PROTEIN; UBIDECARENONE; VITAMIN D;

ACUPUNCTURE; ARTICLE; BREATHING PATTERN; CATHETER; CRATAEGUS; DIET SUPPLEMENTATION; GARLIC; HERBAL MEDICINE; HIGH FIBER DIET; HUMAN; HYPERTENSION; ISOMETRIC EXERCISE; LIFESTYLE MODIFICATION; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAUWOLFIA; VEGETARIAN DIET; VISCUM ALBUM;

BREATHING EXERCISES; DIETARY SUPPLEMENTS; ELECTRIC STIMULATION THERAPY; EXERCISE; HUMANS; HYPERTENSION; LIFE STYLE; PLANT PREPARATIONS; TREATMENT OUTCOME;

EID: 80355133288     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2011.00524.x     Document Type: Article

References (84)

1. Appel LJ, Brands MW, Daniels SR, et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47:296-308.
2. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117-1124.
3. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001;344:3-10.
4. Group WGotPCR. Effects of comprehensive lifestyle modification on blood pressure control. JAMA. 2003;289:2083-2093.
5. Klatsky AL, Friedman GD, Siegelaub AB, Gérard MJ. Alcohol consumption and blood pressure. N Engl J Med. 1977;296:1194-1200.
6. Fuchs FD, Chambless LE, Whelton PK, et al. Alcohol consumption and the incidence of hypertension: the atherosclerosis risk in communities study. Hypertension. 2001;37:1242-1250.
7. Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38:1112-1117.
8. Beulens JWJ, Rimm EB, Ascherio A, et al. Alcohol consumption and risk for coronary heart disease among men with hypertension. Ann Intern Med. 2007;146:10-19.
9. Malinski MK, Sesso HD, Lopez-Jimenez F, et al. Alcohol consumption and cardiovascular disease mortality in hypertensive men. Arch Intern Med. 2004;164:623-628.
10. Najem B, Houssiere A, Pathak A, et al. Acute cardiovascular and sympathetic effects of nicotine replacement therapy. Hypertension. 2006;47:1162-1167.
11. Bowman TS, Gaziano JM, Buring JE, Sesso HD. A prospective study of cigarette smoking and risk of incident hypertension in women. J Am Coll Cardiol. 2007;50:2085-2092.
12. Mikkelsen KL, Wiinberg N, Hoegholm A, et al. Smoking related to 24-h ambulatory blood pressure and heart rate. Am J Hypertens. 1997;10:483-491.
13. Green MS, Jucha E, Luz Y. Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J. 1986;111:932-940.
14. Primatesta P, Falaschetti E, Gupta S, et al. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension. 2001;37:187-193.
15. Dickinson HO, Nicolson DJ, Campbell F, et al. Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006;3:CD004641.
16. He FJ, Markandu ND, Coltart R, et al. Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives. Hypertension. 2005;45:571-574.
17. Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 1997;277:1624-1632.
18. Bianchetti MG, Weidmann P, Beretta-Piccoli C, Ferrier C. Potassium and norepinephrine- or angiotensin-mediated pressor control in pre-hypertension. Kidney Int. 1987;31:956-963.
19. Wu G, Tian H, Han K, et al. Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension. Clin Exp Hypertens. 2006;28:489-497.
20. Ando K, Matsui H, Fujita M, Fujita T. Protective effect of dietary potassium against cardiovascular damage in salt-sensitive hypertension: possible role of its antioxidant action. Curr Vasc Pharmacol. 2010;8:59-63.
21. Pikilidou MI, Befani CD, Sarafidis PA, et al. Oral calcium supplementation ambulatory blood pressure and relation to changes in intracellular ions and sodium-hydrogen exchange. Am J Hypertens. 2009;22:1263-1269.
22. Reid IR, Ames R, Mason B, et al. Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial. Am J Clin Nutr. 2010;91:131-139.
23. Kim DH, Sabour S, Sagar UN, et al. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol. 2008;102:1540-1544.
24. Wu SH, Ho SC, Zhong L. Effects of vitamin D supplementation on blood pressure. South Med J. 2010;103:729-737.
25. Ng X, Boyd L, Dufficy L, et al. Folate nutritional genetics and risk for hypertension in an elderly population sample. J Nutrigenet Nutrigenomics. 2009;2:1-8.
26. Forman JP, Rimm EB, Stampfer MJ, Curhan GC. Folate intake and the risk of incident hypertension among US women. JAMA. 2005;293:320-329.
27. Cagnacci A, Cannoletta M, Volpe A. High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. Eur J Clin Nutr. 2009;63:1266-1268.
28. Yamagami T, Shibata N, Folkers K. Bioenergetics in clinical medicine. Studies on coenzyme Q10 and essential hypertension. Res Commun Chem Pathol Pharmacol. 1975;11:273-288.
29. Rosenfeldt FL, Haas SJ, Krum H, et al. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens. 2007;21:297-306.
30. Cicero AF, Derosa G, Di Gregori V, et al. Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. Clin Exp Hypertens. 2010;32:137-144.
31. Mori TA, Burke V, Puddey I, et al. The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial. J Hypertens. 2009;27:1863-1872.
32. Geleijnse JM, Giltay EJ, Grobbee DE, et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002;20:1493-1499.
33. Ried K, Frank OR, Stocks NP. Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: a randomised controlled trial. Maturitas. 2010;67:144-150.
34. Reinhart KM, Coleman CI, Teevan C, et al. Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother. 2008;42:1766-1771.
35. Simons S, Wollersheim H, Thien T. A systematic review on the influence of trial quality on the effect of garlic on blood pressure. Neth J Med. 2009;67:212-219.
36. He J, Gu D, Wu X, et al. Effect of soybean protein on blood pressure: a randomized, controlled trial. Ann Intern Med. 2005;143:1-9.
37. Fraga CG, Litterio MC, Prince PD, et al. Cocoa flavanols: effects on vascular nitric oxide and blood pressure. J Clin Biochem Nutr. 2011;48:63-67.
38. Taubert D, Roesen R, Schomig E. Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med. 2007;167:626-634.
39. Ried K, Sullivan T, Fakler P, et al. Does chocolate reduce blood pressure? A meta-analysis. BMC Med. 2010;8:39.
40. Margetts BM, Beilin LJ, Vandongen R, Armstrong BK. Vegetarian diet in mild hypertension: a randomised controlled trial. Br Med J (Clin Res Ed). 1986;293:1468-1471.
41. Streppel MT, Arends LR, van't Veer P, et al. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med. 2005;165:150-156.
42. Whelton SP, Hyre AD, Pedersen B, et al. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens. 2005;23:475-481.
43. Walker AF, Marakis G, Morris AP, Robinson PA. Promising hypotensive effect of hawthorn extract: a randomized double-blind pilot study of mild, essential hypertension. Phytother Res. 2002;16:48-54.
44. Walker AF, Marakis G, Simpson E, et al. Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial. Br J Gen Pract. 2006;56:437-443.
45. Baumann G, Felix S, Sattelberger U, Klein G. Cardiovascular effects of forskolin (HL 362) in patients with idiopathic congestive cardiomyopathy - a comparative study with dobutamine and sodium nitroprusside. J Cardiovasc Pharmacol. 1990;16:93-100.
46. Ye F, Du GZ, Cui AQ, Lu XT. Study on the mechanism of compound mistletoe fluid extract in relieving hypertension. J Tradit Chin Med. 2009;29:291-295.
47. Radenkovic M, Ivetic V, Popovic M, et al. Effects of mistletoe (Viscum album L., Loranthaceae) extracts on arterial blood pressure in rats treated with atropine sulfate and hexocycline. Clin Exp Hypertens. 2009;31:11-19.
48. Mc GM, Segel N. The Rauwolfia alkaloids in the treatment of hypertension. Br Heart J. 1955;17:391-396.
49. Lee H, Kim SY, Park J, et al. Acupuncture for lowering blood pressure: systematic review and meta-analysis. Am J Hypertens. 2009;22:122-128.
50. Kim LW, Zhu J. Acupuncture for essential hypertension. Altern Ther Health Med. 2010;16:18-29.
51. Anderson JW, Liu C, Kryscio RJ. Blood pressure response to transcendental meditation: a meta-analysis. Am J Hypertens. 2008;21:310-316.
52. Ospina MB, Bond K, Karkhaneh M, et al. Meditation practices for health: state of the research. Evid Rep Technol Assess (Full Rep). 2007;155:1-263.
53. Mansoor GA. Herbs and alternative therapies in the hypertension clinic. Am J Hypertens. 2001;14:971-975.
54. Zullino D, Borgeat F. Hypertension induced by St. John's Wort - a case report. Pharmacopsychiatry. 2003;36:32.
55. Chapleau MA. Arterial baroreflexes. In: Izzo J, Sica DA, Black HR, eds. Hypertension Primer. 4th ed. London, UK: Lippincott Williams & Wilkins; 2008:120-123.
56. Lohmeier TE, Hildebrandt DA, Warren S, et al. Recent insights into the interactions between the baroreflex and the kidneys in hypertension. Am J Physiol Regul Integr Comp Physiol. 2005;288:R828-R836.
57. Bisognano J, Sloand J, Papademetriou V, et al. An implantable carotid sinus baroreflex activating system for drug-resistant hypertension: interim chronic efficacy results from the multi-center rheos feasibility trial. Circulation. 2006;114:II-575-a-, Abstract 2751.
58. Illig KA, Levy M, Sanchez L, et al. An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial. J Vasc Surg. 2006;44:1213-1218.
59. Scheffers IJ, Kroon AA, Schmidli J, et al. Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol. 2010;56:1254-1258.
60. Bisognano JD, Sica D, Nadim M, et al. Results from the Rheos Pivotal Trial: baroreflex activation therapy sustainably lowers blood pressure in patients with resistant hypertension. New Orleans, LA: American College of Cardiology Scientific Sessions; 2011.
61. Augustyniak RA, Tuncel M, Zhang W, et al. Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens. 2002;20:3-9.
62. DiBona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens. 2002;11:197-200.
63. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34:724-728.
64. Siddiqi L, Joles JA, Grassi G, Blankestijn PJ. Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system? J Hypertens. 2009;27:1341-1349.
65. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-1281.
66. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24months. Hypertension. 2011;57:911-917.
67. Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-1909.
68. Pitzalis MV, Mastropasqua F, Massari F, et al. Effect of respiratory rate on the relationships between RR interval and systolic blood pressure fluctuations: a frequency-dependent phenomenon. Cardiovasc Res. 1998;38:332-339.
69. Novak V, Novak P, de Champlain J, Nadeau R. Altered cardiorespiratory transfer in hypertension. Hypertension. 1994;23:104-113.
70. Cooke WH, Cox JF, Diedrich AM, et al. Controlled breathing protocols probe human autonomic cardiovascular rhythms. Am J Physiol. 1998;274:H709-H718.
71. Schein MH, Gavish B, Herz M, et al. Treating hypertension with a device that slows and regularises breathing: a randomised, double-blind controlled study. J Hum Hypertens. 2001;15:271-278.
72. Rosenthal T, Alter A, Peleg E, Gavish B. Device-guided breathing exercises reduce blood pressure: ambulatory and home measurements. Am J Hypertens. 2001;14:74-76.
73. Meles E, Giannattasio C, Failla M, et al. Nonpharmacologic treatment of hypertension by respiratory exercise in the home setting. Am J Hypertens. 2004;17:370-374.
74. Howden R, Lightfoot J, Brown S, Swaine I. The effects of isometric exercise training on resting blood pressure and orthostatic tolerance in humans. Exp Physiol. 2002;87:507-515.
75. Ray CA, Carrasco DI. Isometric handgrip training reduces arterial pressure at rest without changes in sympathetic nerve activity. Am J Physiol Heart Circ Physiol. 2000;279:H245-H249.
76. Wiley RL, Dunn CL, Cox RH, et al. Isometric exercise training lowers resting blood pressure. Med Sci Sports Exerc. 1992;24:749-754.
77. Taylor AC, McCartney N, Kamath MV, Wiley RL. Isometric training lowers resting blood pressure and modulates autonomic control. Med Sci Sports Exerc. 2003;35:251-256.
78. Millar PJ, MacDonald MJ, Bray SR, McCartney N. Isometric handgrip exercise improves acute neurocardiac regulation. Eur J Appl Physiol. 2009;107:509-515.
79. Peters PG, Alessio HM, Hagerman AE, et al. Short-term isometric exercise reduces systolic blood pressure in hypertensive adults: possible role of reactive oxygen species. Int J Cardiol. 2006;110:199-205.
80. McGowan C, Visocchi A, Faulkner M, et al. Isometric handgrip training improves local flow-mediated dilation in medicated hypertensives. Eur J Appl Physiol. 2007;99:227-234.
81. Millar PJ, Bray SR, McGowan CL, et al. Effects of isometric handgrip training among people medicated for hypertension: a multilevel analysis. Blood Press Monit. 2007;12:307-314.
82. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
83. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-838.
84. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.